The total return over the past 12 months is +137.50% vs. +16.94% for the S&P 500. So far it's up +52.23% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +137.50% | +55.19% | +21.54% | N/A | N/A | N/A |
| Total Return CAGR | +137.50% | +55.19% | +21.54% | N/A | N/A | N/A |
| Revenue CAGR | +92.92% | +163.80% | +18.60% | +28.54% | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | +27.41% | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | +21.07% | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
AnaptysBio, Inc. (ANAB)
| Year | Start price | End price | ANAB Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $32.32 | $49.20 | +52.23% | +14.51% | +37.72% |
| 2025 | $8.83 | $32.32 | +266.02% | +17.72% | +248.30% |
| 2024 | $14.28 | $8.83 | (38.17%) | +24.89% | (63.06%) |
| 2023 | $20.66 | $14.28 | (30.88%) | +26.19% | (57.07%) |
| 2022 | $23.17 | $20.66 | (10.83%) | (18.17%) | +7.34% |
| 2021 | $14.33 | $23.17 | +61.69% | +28.74% | +32.95% |
| 2020 | $10.83 | $14.33 | +32.32% | +18.37% | +13.95% |
| 2019 | $42.53 | $10.83 | (74.54%) | +31.22% | (105.76%) |
| 2018 | $67.15 | $42.53 | (36.66%) | (4.56%) | (32.10%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
